No Data
No Data
BrainStorm CEO to Discuss Phase 3b ALS Trial at Maxim Healthcare Virtual Summit
Express News | Brainstorm Cell Therapeutics to Provide Corporate Update on Phase 3B Nurown® Trial at the 2024 Maxim Healthcare Virtual Summit
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Brainstorm Cell Therapeutics To Carry Out 1-for-15 Reverse Stock Split On October 1st, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
No Data
No Data